Arformoterol Tartrate Inhalation 15 ug/2mL
Arformoterol Tartrate Inhalation · SOLUTION · Devatis, Inc.
Arformoterol Tartrate Inhalation is a solution containing arformoterol tartrate inhalation at 15 ug/2mL, taken respiratory (inhalation). Manufactured by Devatis, Inc..
Key Facts
- Brand Name
- Arformoterol Tartrate Inhalation
- Generic Name
- Arformoterol Tartrate Inhalation
- NDC Code (Product)
73043-052- Manufacturer
- Devatis, Inc.
- Strength
- 15 ug/2mL
- Dosage Form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- ANDA218429
- Marketing Start
- 08/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Arformoterol Tartrate Inhalation used for?
Arformoterol Tartrate Inhalation contains Arformoterol Tartrate Inhalation. It is a solution taken respiratory (inhalation). Consult your doctor for specific uses.
Is Arformoterol Tartrate Inhalation a controlled substance?
Arformoterol Tartrate Inhalation is not classified as a controlled substance by the DEA.
What is the generic name for Arformoterol Tartrate Inhalation?
The generic name for Arformoterol Tartrate Inhalation is Arformoterol Tartrate Inhalation. There are 1 other brand versions of Arformoterol Tartrate Inhalation.
What is the NDC code for Arformoterol Tartrate Inhalation 15 ug/2mL?
The NDC (National Drug Code) for Arformoterol Tartrate Inhalation 15 ug/2mL is 73043-052, listed by Devatis, Inc..